Therapeutic agent
US7691897B2 · kind B2 · utility
1Cited by
6References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 17, 2006 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Jan 17, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Agent for the depletion of an unwanted protein population from the plasma of a subject, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of the proteins in the presence thereof, wherein at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the proteins, wherein the agent is a non-proteinaceous agent other than a D-proline of the formulawherein the group
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.